Clinical Trials Browser

Phase 1 × Erectile Dysfunction × Clear all

NCT05332340 2025-03-07

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Phase 1 Completed

12 enrolled 10 charts

Erectile Dysfunction, Prostatic Neoplasms